ArticleJournal of clinical hypertension (Greenwich, Conn.)2025
Association of Retinal Arterial Narrowing With New-Onset Carotid Plaque: A Chinese Community-Based Nested Case-Control Cohort Study.
Article in Journal of clinical hypertension (Greenwich, Conn.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and temporal validation of five year retinal arteriosclerosis risk prediction in high risk adults from an East China cohort.Scientific reports · 2026Article
- Diabetes Status Modifies the Association Between Carotid Plaque Burden and Retinal Microvascular Parameters.International journal of medical sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To investigate whether retinal arterial narrowing is associated with incident carotid plaque in the general population. Individuals without carotid plaque in 2014 who developed new-onset carotid plaque in 2018 were selected as cases (n = 156) for the atherosclerosis group and matched for age and sex in a ratio of 1:1 for the control group. The effects of the baseline central retinal arteriolar equivalent (CRAE), central retinal venular equivalent (CRVE), and arteriovenous ratio (AVR) on the risk of new-onset carotid plaque were evaluated in multivariable conditional logistic regression models. Subgroup analyses were performed. The mean CRAE, CRVE, and AVR were 153.03 ± 12.77 µm, 232.41 ± 19.78 µm, and 0.66 ± 0.07, respectively. After adjusting for multiple variables, the risk of developing new-onset carotid plaque increased by 4% (odds ratio [OR] 1.04, 95% confidence interval [CI] 1.02-1.07, p < 0.01) with each 1-µm decrease in CRAE and 80% (OR 1.80, 95% CI 1.17-2.78, p < 0.01) with each 0.1-point decline in AVR. When CRAE and AVR were considered as categorical variables, compared with subjects in the highest CRAE and AVR groups, those in the lowest CRAE and AVR groups had a 159% (OR 2.59, 95% CI 1.34-5.01, p < 0.01) and 93% (OR 1.93, 95% CI 1.08-3.46, p = 0.03) increase in risk of developing new-onset carotid plaque, respectively. However, CRVE was not significantly related to new-onset carotid plaque. Subgroup and interaction analyses were performed, and no significant modification effect was found. In conclusion, retinal arterial narrowing was strongly related to the risk of incident carotid plaque.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.